Esma chair hits back against regulatory overreach claims

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

The chairman of the European Securities and Markets Authority (Esma), Steven Maijoor, has hit back at accusations that the supervisor overstepped its mandate when drawing up regulatory technical standards for the clearing of over-the-counter derivatives.

The European Parliament's influential Economic and Monetary Affairs (Econ) Committee voted on February 4 to reject two regulatory technical standards, primarily because it felt Esma had gone too far in interpreting certain requirements set out

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]